Wan-Chi Lin, Ph.D.
Affiliations: | 2011 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
OncologyGoogle:
"Wan-Chi Lin"Parents
Sign in to add mentorKay-Uwe Wagner | grad student | 2011 | University of Nebraska Medical Center | |
(The Role of c-Myc in Pancreatic Cancer Initiation and Progression.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nie L, Wei Y, Zhang F, et al. (2019) CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer. Nature Communications. 10: 5114 |
Rajbhandari N, Lin WC, Wehde BL, et al. (2017) Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers. Cell Reports. 18: 2243-2255 |
Du Y, Yamaguchi H, Wei Y, et al. (2016) Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors. Nature Medicine |
Witkiewicz AK, McMillan EA, Balaji U, et al. (2015) Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nature Communications. 6: 6744 |
Lin WC, Rajbhandari N, Wagner KU. (2014) Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: a lingering challenge in the development of targeted therapies. Cancer Research. 74: 2138-43 |
Lin WC, Schmidt JW, Creamer BA, et al. (2013) Gain-of-function of Stat5 leads to excessive granulopoiesis and lethal extravasation of granulocytes to the lung. Plos One. 8: e60902 |
Lin WC, Rajbhandari N, Liu C, et al. (2013) Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer Research. 73: 1821-30 |
Lin W, Rajbhandari N, Liu C, et al. (2012) Abstract LB-429: Dormant cancer cells contribute to residual disease in a mouse model for reversible pancreatic cancer Cancer Research. 72 |
Zhang Q, Sakamoto K, Liu C, et al. (2011) Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression. Cancer Research. 71: 7513-24 |
Lin W, Zhang Q, Opavsky R, et al. (2011) Abstract 2384: A novel mouse model for the study of c-MYC during initiation and progression of pancreatic ductal adenocarcinoma Cancer Research. 71: 2384-2384 |